In addition, BRCA1 haploinsufficiency upregulates RANKL expression and cell proliferation [165], which contributes significantly to TNBC tumorigenesis from the cell-of-origin [137,138], and RANKL inhibition markedly attenuates tumor onset [139,140]. The gene discussed is BRCA1; the disease is neoplasm.